Marc Hedrick News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marc hedrick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marc Hedrick Today - Breaking & Trending Today

Plus Therapeutics Announces Private Placement Financing of up to $18 Million - Plus Therapeutics (NASDAQ:PSTV)

AUSTIN, Texas, May 06, 2024 (GLOBE NEWSWIRE) Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies ....

San Antonio , United States , Charles Huang , Marc Hedrick , Capital Management , Securities Exchange , Therapeutics Inc , Exchange Commission , Securities Act , Securities Exchange Act , Financial Condition , Capital Markets ,

This Biotech Is Creating Targeted Radiotherapuetics For Some Of The Deadliest Cancers

Marc Hedrick, President & CEO of Plus Therapeutics PSTV, recently presented at Benzinga's Virtual HealthCare Summit 2024. Plus Therapeutics is a… ....

Marc Hedrick , Plus Therapeutics , Virtual Healthcare Summit , Reaking News ,

Plus Therapeutics, Inc. (NASDAQ:PSTV) Q3 2023 Earnings Call Transcript

Plus Therapeutics, Inc. (NASDAQ:PSTV) Q3 2023 Earnings Call Transcript October 31, 2023 Operator: Good afternoon, ladies and gentlemen. Welcome to the Plus Therapeutics Third Quarter 2023 Results Conference Call. Before we begin, we want to advise you that over the course of the call and question-and-answer session, forward-looking statements will be made regarding events, trends, […] ....

United States , British Columbia , Marc Hedrick , Norman Lafrance , Justin Walsh , Andrew Brenner , Andrew Sims , Society For Neuro , Chief Financial Officer , Chief Medical , Rhenium Obisbemeda , Lurie Children , Stressful Jobs , Polluted States , Andrew Sims , Phase Ii Trial , Radiation Doses , Forward Looking Statements ,

Targeted Cancer Treatment: Plus Therapeutics CEO Marc Hedrick, Live from NYSE

Healthcare Edge hosted a fireside chat from the floor of the New York Stock Exchange with Marc Hedrick, M.D., President and CEO of Plus Therapeutics, Inc. (Nasdaq: PSTV). Dr. Hedrick spoke to Healthcare Edge Editor-in-Chief John Jannarone about its novel targeted radio-therapeutics treatment for central nervous system cancer using the latest technology, its future potential […] ....

University Of Texas Southwestern Medical School , United States , San Antonio , Anderson School , Los Angeles , John Jannarone , Marc Hedrick , Cytori Therapeutics Inc , York Stock Exchange , New York Stock Exchange , Therapeutics Inc , Research Institute Of Texas , Stemsource Inc , University Of California , Laboratory Of Regenerative , Healthcare Edge , Plus Therapeutics , Healthcare Edge Editor In Chief John Jannarone , Cancer Prevention , Research Institute , Cytori Therapeutics , Associate Professor , Regenerative Bioengineering , Texas Southwestern Medical School , Plus Therapeutics , Resident And Ceo ,

EXCLUSIVE: Cancer Firm Plus Therapeutics Licenses Diagnostic Assay To Detect Central Nervous System Cancers - Plus Therapeutics (NASDAQ:PSTV)

Plus Therapeutics Inc (NASDAQ: PSTV) has expanded its supply agreement with Biocept Inc (NASDAQ: BIOC) by acquiring an option to exclusively license Biocept's CNSide, a cerebrospinal flu ....

Marc Hedrick , Biocept Inc , Plus Therapeutics , Plus Therapeutic ,